For other functions project: acquisition of colony stimulating factor(s) (g-CSF or GM-CSF) for mitigation of neutropenia arising from exposure to ionizing radiation (rtor-CSF-0003)
Ended Awarded
- Contract number
- HHSO10033002T
- Awardee
-
Amgen USA Inc. UEI XPGNQMXHP493
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $37,675,457
Award facts
- Opportunity
-
- 12100SOL00016 Solicitation number
- Acquisition of Colony Stimulating Factor(s) (G-CSF or GM-CSF) for mitigation of Neutropenia arising from exposure to ionizing radiation Award Notice · Posted Sep 30, 2016
- Contract value 100% obligated
- $37,675,456.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Thousand Oaks, CA 91320, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Amgen USA Inc., a division of the biotechnology company Amgen, by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract, valued at $37,675,456.54, is for the acquisition of a colony stimulating factor, either G-CSF or GM-CSF, to mitigate neutropenia arising from exposure to ionizing radiation. This is a delivery order contract under the HHS Colony Stimulating Factor 2013-2018 IDIQ contract, a multiple-award indefinite delivery vehicle. The contract is a firm fixed-price arrangement and does not have a set-aside designation. Amgen USA Inc. is the prime contractor on this award, and the ultimate completion date is September 29, 2021. This contract supports the agency's efforts to acquire medical countermeasures for serious threats, such as radiological and nuclear events.
Quick answers
Who was awarded contract HHSO10033002T?
HHSO10033002T was awarded to Amgen USA Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2016.
How much is contract HHSO10033002T worth?
The government has obligated $37,675,457 on HHSO10033002T.
Is contract HHSO10033002T an order under another contract?
Yes. HHSO10033002T is a delivery order under HHSO100201300006I, an indefinite delivery contract, on HHS Colony Stimulating Factor 2013-2018.
Was contract HHSO10033002T competed?
The extent of competition for HHSO10033002T was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award